Gatifloxacin (Compound)

Synonyms:Gatifloxacin, 112811-59-3, Tequin, Gatiflo, Zymar, AM-1155, Zymaxid, gatifloxacin anhydrous, AM 1155, Zymer, CG 5501, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, BMS-206584, GTFX, BMS 206584-01, PD 135432, 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, Gatifloxacin hydrate, Gatifloxacin (INN), CHEMBL31, 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-, NSC-758701, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid, PD-135432, CHEBI:5280, DTXSID5045704, Gatilox, Gatiquin, Gatispan, 160738-57-8, Gaity, CG5501, MFCD00895399, 81485Y3A9A, gatifloxin, NCGC00068236-02, Gatifloxacin 100 microg/mL in Acetonitrile, GATIFLOXACIN [INN], 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid, Gatifloxacin [USAN:INN], BMS-206584-01, DTXCID3025704, Bonoq, Gatifloxacin (sesquihydrate), Tymer, (+/-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid, 3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-, SMR000043336, Gatifloxacin (TN), CAS-112811-59-3, Zymer (TN), 1-cyclopropyl-6-fluoro-8-methoxy-7-, SR-01000610458, (3-methylpiperazin-1-yl)-4-oxo-1,4-, BMS-20658401, gatifloxacino, gatifloxacinum, Gatifloxcin, Tequin in dextrose 5% in plastic container, AM-1155 (*Sesquihydrate*), Gatifloxacin & Gamma Interferon, UNII-81485Y3A9A, Gatifloxacin,(S), (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, CG-5501, Kinome_3137, Spectrum_001909, CPD000043336, PD135432, Spectrum2_000487, Spectrum3_000999, Spectrum4_001127, Spectrum5_001468, GATIFLOXACIN [MI], SCHEMBL22591, BSPBio_002697, KBioGR_001613, KBioSS_002448, 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, MLS000040259, MLS000759493, MLS006011836, GATIFLOXACIN [WHO-DD], SPECTRUM1504272, SPBio_000353, Gatifloxacin Sesquihydrate,(S), GTPL10816, KBio2_002442, KBio2_005010, KBio2_007578, KBio3_001917, HMS1922J15, HMS2090K10, HMS2093G06, HMS2233D20, HMS3259P06, HMS3372J10, HMS3372J12, HMS3715N03, Pharmakon1600-01504272, ALBB-028535, AMY17781, BCP13408, RKL10068, Tox21_110984, BBL010485, BDBM50117914, CCG-39529, HB3263, NSC758701, s1340, STK801620, C19H22FN3O4.1.5H2O, AKOS004119932, AKOS016340697, Tox21_110984_1, AC-1944, CS-1841, DB01044, KS-1066, NC00702, NSC 758701, NCGC00068236-03, NCGC00068236-04, NCGC00068236-05, NCGC00068236-06, NCGC00068236-07, NCGC00068236-08, NCGC00095126-01, NCGC00095126-02, NCGC00178525-01, HY-10581, SBI-0206764.P001, DB-019145, FT-0626635, FT-0631189, FT-0668952, G0325, C07661, D08011, G-2380, AB00171654-13, AB00171654-14, AB00171654_16, AB00171654_17, A802657, EN300-19768783, Gatifloxacin, Antibiotic for Culture Media Use Only, Q2365016, SR-01000610458-2, SR-01000610458-3, BRD-A74980173-001-02-8, BRD-A74980173-001-06-9, Z1824566854, 1-Cyclopropyl-6-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid, 1-Cyclopropyl-6-6-fluoro-1,4-dihydro-8-methoxy-7-(3methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid, 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic a, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazino)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid, 1-cyclopropyl-7-(3-methyl-1-piperazinyl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Pubchem:PUBCHEM:5379
Id:da0efa48-a775-558b-ad32-f556828437ed
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Gatifloxacin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Gatifloxacin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Gatifloxacin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.